Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. OrganoClick AB's EBITDA for the
three
months ended in Mar. 2026 was €0.37 Mil. OrganoClick AB's Revenue for the
three
months ended in Mar. 2026 was €2.54 Mil. Therefore, OrganoClick AB's EBITDA margin for the quarter that ended in Mar. 2026 was 14.44%.
OrganoClick AB (FRA:0CF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
OrganoClick AB EBITDA Margin % Related Terms
OrganoClick AB EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for OrganoClick AB's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:0CF vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, OrganoClick AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
OrganoClick AB EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, OrganoClick AB's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where OrganoClick AB's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OrganoClick AB (FRA:0CF) has a EBITDA Margin % of 14.44% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on OrganoClick AB and its competitors. According to the industry distribution chart, OrganoClick AB ranks #1437 out of 1578 companies in the Chemicals industry, placing it in the top 91.1%.
Is OrganoClick AB's EBITDA Margin % too high?
OrganoClick AB's current EBITDA Margin % is 14.44%. The Chemicals industry median EBITDA Margin % is 9.63. OrganoClick AB's value of 14.44% is 50% above this industry median. Based on the distribution chart, OrganoClick AB ranks #1437 out of 1578 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, OrganoClick AB has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does OrganoClick AB's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, OrganoClick AB ranks #1437 out of 1578 companies for EBITDA Margin %. This places OrganoClick AB in the lower half of its industry. The industry median EBITDA Margin % is 9.63. OrganoClick AB's value of 14.44% is 50% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.63, based on 1,578 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. OrganoClick AB's current EBITDA Margin % of 14.44% is 50% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on OrganoClick AB and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. OrganoClick AB's current EBITDA Margin % is 14.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrganoClick AB stock overvalued right now?
OrganoClick AB (FRA:0CF) has a current EBITDA Margin % of 14.44%. The stock's GF Value™ is €0.14, compared to a current price of €0.02 — trading 82.7% below its estimated fair value. The current EBITDA Margin % is 14.44% and 50% above the Chemicals industry median of 9.63. OrganoClick AB's overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For OrganoClick AB (FRA:0CF), the current EBITDA Margin % is 14.44% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is OrganoClick AB (FRA:0CF) Overvalued in 2026?
Based on GuruFocus' analysis, OrganoClick AB stock appears to be undervalued.
The current stock price of €0.02 is trading 82.7% below its estimated GF Value™ of €0.14.
Key valuation signals for FRA:0CF:
EBITDA Margin %: 14.44%
GF Value™: €0.14 vs. price of €0.02 (82.7% below fair value)
Industry Position: 50% above the Chemicals median (#1437 of 1578)
No single metric tells the full story. See the FRA:0CF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
OrganoClick AB is involved in the chemicals industry. Its product portfolio includes green chemical technologies for creating water repellency, biobased binders for increasing the mechanical strength, and wood treatment products for resistance to fungal degradation and resistance to fire. It operates in four business areas Functional Wood, Green coatings & maintenance products, Nonwoven & technical textile, and Other. The group has a single operating segment.
25GF Score
Get the complete analysis for FRA:0CF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:0CF has been successfully added to your 
